Cytotoxic T lymphocytes: Sniping cancer stem cells

Cancer stem cells (CSCs)/cancer-initiating cells (CICs) are characterized as a small population of cancer cells that have high tumor-initiating ability. CSCs/CICs are resistant to several cancer therapies, and eradication of CSCs/CICs is essential to cure cancer. How can we eradicate CSCs/CICs? Cyto...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirohashi, Yoshihiko, Torigoe, Toshihiko, Inoda, Satoko, Morita, Rena, Kochin, Vitaly, Sato, Noriyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376951/
https://www.ncbi.nlm.nih.gov/pubmed/22720232
http://dx.doi.org/10.4161/onci.1.1.18075
_version_ 1782235893544779776
author Hirohashi, Yoshihiko
Torigoe, Toshihiko
Inoda, Satoko
Morita, Rena
Kochin, Vitaly
Sato, Noriyuki
author_facet Hirohashi, Yoshihiko
Torigoe, Toshihiko
Inoda, Satoko
Morita, Rena
Kochin, Vitaly
Sato, Noriyuki
author_sort Hirohashi, Yoshihiko
collection PubMed
description Cancer stem cells (CSCs)/cancer-initiating cells (CICs) are characterized as a small population of cancer cells that have high tumor-initiating ability. CSCs/CICs are resistant to several cancer therapies, and eradication of CSCs/CICs is essential to cure cancer. How can we eradicate CSCs/CICs? Cytotoxic T lymphocytes (CTLs) might be a promising answer.
format Online
Article
Text
id pubmed-3376951
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-33769512012-06-20 Cytotoxic T lymphocytes: Sniping cancer stem cells Hirohashi, Yoshihiko Torigoe, Toshihiko Inoda, Satoko Morita, Rena Kochin, Vitaly Sato, Noriyuki Oncoimmunology Author's View Cancer stem cells (CSCs)/cancer-initiating cells (CICs) are characterized as a small population of cancer cells that have high tumor-initiating ability. CSCs/CICs are resistant to several cancer therapies, and eradication of CSCs/CICs is essential to cure cancer. How can we eradicate CSCs/CICs? Cytotoxic T lymphocytes (CTLs) might be a promising answer. Landes Bioscience 2012-01-01 /pmc/articles/PMC3376951/ /pubmed/22720232 http://dx.doi.org/10.4161/onci.1.1.18075 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Hirohashi, Yoshihiko
Torigoe, Toshihiko
Inoda, Satoko
Morita, Rena
Kochin, Vitaly
Sato, Noriyuki
Cytotoxic T lymphocytes: Sniping cancer stem cells
title Cytotoxic T lymphocytes: Sniping cancer stem cells
title_full Cytotoxic T lymphocytes: Sniping cancer stem cells
title_fullStr Cytotoxic T lymphocytes: Sniping cancer stem cells
title_full_unstemmed Cytotoxic T lymphocytes: Sniping cancer stem cells
title_short Cytotoxic T lymphocytes: Sniping cancer stem cells
title_sort cytotoxic t lymphocytes: sniping cancer stem cells
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376951/
https://www.ncbi.nlm.nih.gov/pubmed/22720232
http://dx.doi.org/10.4161/onci.1.1.18075
work_keys_str_mv AT hirohashiyoshihiko cytotoxictlymphocytessnipingcancerstemcells
AT torigoetoshihiko cytotoxictlymphocytessnipingcancerstemcells
AT inodasatoko cytotoxictlymphocytessnipingcancerstemcells
AT moritarena cytotoxictlymphocytessnipingcancerstemcells
AT kochinvitaly cytotoxictlymphocytessnipingcancerstemcells
AT satonoriyuki cytotoxictlymphocytessnipingcancerstemcells

Ejemplares similares